×

Merck's new weapon in fight against cancer

8:03 AM ET Wed, 4 June 2014

Ken Frazier, Merck chairman & CEO, discusses the latest immune drug for treating melanoma and lung cancer. Also Frazier weighs in on the high cost of drugs.